Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Clinical trial NCT07284654 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07284654
Sponsor: Vaxcyte, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2025-12-01
Primary completion: 2027-01-01
Enrollment: 4049

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.